These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
69 related items for PubMed ID: 1713880
1. Toxic effects of alkyl-lysophospholipids on human bone marrow and de novo leukaemias. A short overview. Wötzel M, Brachwitz H, Langen P, Thierbach V. Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(6):771-6. PubMed ID: 1713880 [Abstract] [Full Text] [Related]
3. The cytotoxicity of alkyl-lysophospholipid on clonogenic leukemia cells and on normal bone marrow progenitor cells is highly, but differentially, increased by cryopreservation. Verdonck LF, Heesbeen EC, van Heugten HG, Staal GE, Rijksen G. Bone Marrow Transplant; 1992 Apr; 9(4):241-5. PubMed ID: 1600412 [Abstract] [Full Text] [Related]
4. Removal of breast cancer cells from bone marrow by in vitro purging with ether lipids and cryopreservation. Dietzfelbinger HF, Kühn D, Zafferani M, Hanauske AR, Rastetter JW, Berdel WE. Cancer Res; 1993 Aug 15; 53(16):3747-51. PubMed ID: 8339286 [Abstract] [Full Text] [Related]
5. Differential cytotoxicity of an ether lipid on lymphoma and bone marrow cells and its role in purging malignant lymphoid cells from remission bone marrow contaminated with tumor cells. Dietzfelbinger HF, Lang A, Oberberg D, Rastetter JW, Berdel WE. Exp Hematol; 1992 Feb 15; 20(2):178-83. PubMed ID: 1544386 [Abstract] [Full Text] [Related]
8. Selective killing of malignant cells from leukemic patients by alkyl-lysophospholipid. Verdonck LF, Witteveen EO, van Heugten HG, Rozemuller E, Rijksen G. Cancer Res; 1990 Jul 01; 50(13):4020-5. PubMed ID: 2354451 [Abstract] [Full Text] [Related]
10. Peripheral blood and bone marrow changes after treatment with ATRA and G-CSF in AML, APL and blast crisis following Vaquez's disease. Notario A, Rolandi ML, Mazzucchelli I. Haematologica; 1996 Jul 01; 81(3):261-4. PubMed ID: 8767533 [Abstract] [Full Text] [Related]
11. Differential sensitivity to cryopreservation of clonogenic progenitor cells and stromal precursors from leukemic and normal bone marrow. Zaheer HA, Gibson FM, Bagnara M, Gordon-Smith EC, Rutherford TR. Stem Cells; 1994 Mar 01; 12(2):180-6. PubMed ID: 8199561 [Abstract] [Full Text] [Related]
12. The sensitivity of leukemic bone marrow to simvastatin is lost at remission: a potential purging agent for autologous bone marrow transplantation. Newman A, Clutterbuck RD, DeLord C, Powles RL, Catovsky D, Millar JL. J Investig Med; 1995 Jun 01; 43(3):269-74. PubMed ID: 7614073 [Abstract] [Full Text] [Related]
13. Purging leukemic cells from simulated human remission marrow with alkyl-lysophospholipid. Okamoto S, Olson AC, Vogler WR, Winton EF. Blood; 1987 May 01; 69(5):1381-7. PubMed ID: 3471282 [Abstract] [Full Text] [Related]
15. Hydrocortisone in culture protects the blast cells in acute myeloblastic leukemia from the lethal effects of cytosine arabinoside. Yang GS, Wang C, Minkin S, Minden MD, McCulloch EA. J Cell Physiol; 1991 Jul 01; 148(1):60-7. PubMed ID: 1860896 [Abstract] [Full Text] [Related]
16. Influence of cryopreservation on human leukaemic clonogenic cells (CFU-L). Elstner E, Wächter M, Blau IW. Folia Haematol Int Mag Klin Morphol Blutforsch; 1990 Jul 01; 117(2):313-7. PubMed ID: 1697835 [Abstract] [Full Text] [Related]
18. Comparative heat sensitivity of murine and human hemopoietic progenitors and clonogenic leukemia cells. Gidáli J, Fehér I, Kovács P. Stem Cells; 1994 Sep 01; 12(5):533-8. PubMed ID: 7804126 [Abstract] [Full Text] [Related]
19. Heterogenous response of primary cultured bone marrow cells of patients with different varieties of leukemia to differentiation inducers. Chen ZX, Wang W, Wu WL. Chin Med J (Engl); 1989 Mar 01; 102(3):174-82. PubMed ID: 2503303 [Abstract] [Full Text] [Related]
20. Differential effects of phorbol esters on normal myeloid precursors and leukemic cells: basis for autologous bone marrow reconstitution in acute nonlymphocytic leukemia using phorbol ester-treated bone marrow from patients in remission. Abrahm JL, Gerson SL, Hoxie JA, Tannenbaum SH, Cassileth PA, Cooper RA. Cancer Res; 1986 Jul 01; 46(7):3711-6. PubMed ID: 3518922 [Abstract] [Full Text] [Related] Page: [Next] [New Search]